TCR2 Therapeutics Inc. buy melinda
Start price
14.12.20
/
50%
€24.20
Target price
14.12.21
€30.00
Performance (%)
-81.90%
End price
15.12.21
€4.38
Summary
This prediction ended on 15.12.21 with a price of €4.38. The BUY prediction by melinda for TCR2 Therapeutics Inc. performed very badly with a performance of -81.90%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
TCR2 Therapeutics Inc. | - | - | - | - |
iShares Core DAX® | 1.308% | 1.167% | 25.330% | 23.334% |
iShares Nasdaq 100 | -0.156% | 1.246% | 27.119% | 42.230% |
iShares Nikkei 225® | 1.270% | 0.293% | 18.646% | 6.856% |
iShares S&P 500 | 0.476% | 1.292% | 27.786% | 42.845% |
Comments by melinda for this prediction
In the thread Tcr2 Therapeutics Inc. diskutieren
Buy mit Kursziel 30,0
In the thread Trading Tcr2 Therapeutics Inc.
Die von melinda gewählte maximale Laufzeit wurde überschritten